Clinical Trial Update: Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer (mCRC) Participants (MK-3475-651/KEYNOTE-651) [Phase 1]

View source ↗

Summary

Phase 1 study assessing pembrolizumab with binimetinib, alone or with chemotherapy (with or without binimetinib), in metastatic colorectal cancer; results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Binimetinib (binimetinib)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-10-15